EMA Biennial Report 2016/2017: Joint CVMP/CHMP Working group on the Application of the 3Rs in Regulatory Testing of Medical Products

By Anna Jurczynska | March 7, 2018

This report is aimed at informing pharmaceutical companies and the public of the EMA activities in relation to “3Rs” (replacement, reduction, refinement) during 2016 and 2017. The report summarises the recommendations developed and the organisational structure enabling the development of such guidance. It also looks into the future with details about a new mandate to…

Read More

SSFAoggi meets Dr. Honorio Silva, IFAPP President

By Anna Jurczynska | February 19, 2018

    SSFA was one of the 12 founding members of IFAPP, the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine. Indeed, it was during a Conference held in Florence in September 1975 that IFAPP was officially launched, as the first name of the federation was IFAMAPI (International Federation of Associations of Medical…

Read More

Medicines Development and Regulation in Africa

By Anna Jurczynska | October 9, 2017

Africa is one of the world’s fastest-growing economic regions, with a rise in its pharmaceutical industry value from $4.7 billion in 2003 to $20.8 billion in 2013. Multinational pharmaceutical companies are increasingly active in drug production and clinical trials across Africa, and there is an increasing number of local companies engaged in medicines development and…

Read More